Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03750383
What this trial is testing

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 48
Not applicableUnknownNCT01684527
What this trial is testing

Immature Myeloid Cells in Respiratory Syncytial Virus Bronchioliltis

Who this might be right for
Bronchiolitis
Hillel Yaffe Medical Center 55
Early research (Phase 1)Study completedNCT03049488
What this trial is testing

Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus
National Institute of Allergy and Infectious Diseases (NIAID) 95
Not applicableStudy completedNCT01706302
What this trial is testing

Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009

Who this might be right for
Respiratory Syncyctial Virus Vaccines
GlaxoSmithKline 1
Not applicableStudy completedNCT03095495
What this trial is testing

High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)
Hamad Medical Corporation 28
Early research (Phase 1)Active Not RecruitingNCT06216093
What this trial is testing

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)
EuBiologics Co.,Ltd 100
Post-approval studies (Phase 4)Study completedNCT06077149
What this trial is testing

Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)

Who this might be right for
Respiratory Syncytial Virus (RSV)
University of Rochester 152
Not applicableStudy completedNCT05622331
What this trial is testing

Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in Sweden

Who this might be right for
Respiratory Syncytial Virus (RSV)
Sanofi Pasteur, a Sanofi Company 1,100,000
Not applicableUnknownNCT06392451
What this trial is testing

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Who this might be right for
Influenza AInfluenza Type BCoronavirus Disease 2019+8 more
DiaSorin Molecular LLC 1,000
Not applicableUnknownNCT05618769
What this trial is testing

Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants

Who this might be right for
Premature BirthRespiratory DiseaseRespiratory Tract Infections+11 more
Franciscus Gasthuis 330
Testing effectiveness (Phase 2)Study completedNCT03636906
What this trial is testing

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 201
Not applicableStudy completedNCT05164692
What this trial is testing

Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in Children

Who this might be right for
Acute Respiratory Tract Infections
National Children's Hospital, Vietnam 100
Not applicableStudy completedNCT03574532
What this trial is testing

Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)

Who this might be right for
Respiratory Tract Infections
Janssen-Cilag International NV 118
Large-scale testing (Phase 3)Study completedNCT03171142
What this trial is testing

Effect of Heliox on RSV Bronchiolitis

Who this might be right for
RSV InfectionAcute Bronchiolitis
Wael Seliem 104
Testing effectiveness (Phase 2)Study completedNCT03524118
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Who this might be right for
Respiratory Tract InfectionRespiratory Syncytial Virus
Merck Sharp & Dohme LLC 183
Not applicableLooking for participantsNCT06197152
What this trial is testing

Identification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Assistance Publique - Hôpitaux de Paris 133
Not applicableStudy completedNCT06185647
What this trial is testing

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Hôpital Armand Trousseau 4,924
Not applicableActive Not RecruitingNCT05443607
What this trial is testing

Transplacental Transmission of RSV (TTRSV)

Who this might be right for
SARS CoV 2 InfectionRespiratory Syncytial Virus (RSV)Bronchiolitis+1 more
Tulane University 300
Early research (Phase 1)Study completedNCT03102034
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Early research (Phase 1)Study completedNCT04090658
What this trial is testing

Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 40
Next Page